Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer’s amyloidosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer’s amyloidosis ; volume:13 ; number:1 ; day:8 ; month:10 ; year:2021 ; pages:1-16 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (8.10.2021), 1-16, 12.2021
- Urheber
-
Lee, Jaedong
Kwag, Jeehyun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00901-9
- URN
-
urn:nbn:de:101:1-2021122507480996376558
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jaedong
- Kwag, Jeehyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease
Effects of SPI1-mediated transcriptome remodeling on Alzheimer’s disease-related phenotypes in mouse models of Aβ amyloidosis
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease
Effects of SPI1-mediated transcriptome remodeling on Alzheimer’s disease-related phenotypes in mouse models of Aβ amyloidosis
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease